1. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2;Slamon;N Engl J Med,2001
2. The role of gemcitabine in the treatment of other tumours;Carmichael;Br J Cancer,1998
3. Mechanisms of synergism between cisplatin and gemcitabine in ovarian and non-small-cell lung cancer cell lines;van Moorsel;Br J Cancer,1999
4. Heinemann V, Stemmler HJ, Wohlrab B, et al. Gemcitabine and cisplatin +/− trastuzumab (herceptin) in intensively pretreated metastatic breast cancer (MBC) [abstract]. Jahrestagung der DGHO 2002, Munich 27–30 October, 2002.
5. Stemmler HJ, Heinemann V, Brehm G. Response to a triple combination of gemcitabine, cisplatin and herceptin in metastatic breast cancer previously refractory to gemcitabine and herceptin: a case report [abstract]. Jahrestagung der DGHO 1999, Jena 3–6 October, 1999.